Top Articles

Research

Targeting Lactate Metabolism for Cancer Immunotherapy

New study suggests that lactate can rejuvenate immune cells in the fight against cancer and may have additional benefits for immunotherapy.

Lung Cancer; Research

AXL Inhibition Restores Response to PD-1 Blockade in STK11/LKB1-mutant NSCLC

New Simmons Cancer Center research involving investigational drug to target AXL inhibition shows possible benefits for patients with lung adenocarcinomas.

Clinical Trials; Research

Grants Awarded to Expand Clinical Trials Navigation

Simmons Cancer Center researchers have received funding to help patients from diverse backgrounds access and navigate clinical trials.

Lung Cancer; Research

Cellular Stress Response Promotes Immune Evasion in Lung Cancer

Researchers uncover a key mechanism that regulates PD-L1, a protein that helps tumors evade the immune system and is the target of several immunotherapy drugs.